Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Increased hs-CRP and Sepsis Influence the Occurrence of Thrombocytopenia in Severe and Critically Ill COVID-19 Patients Receiving Anticoagulants

The Indonesian Biomedical Journal · Vol. 15 No. 1 (2023) · hlm. 77–84

DOI
10.18585/inabj.v15i1.2045
ISSN
2085-3297, 2355-9179
Terbit
2023-02-23
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Despites its benefits, as one of COVID-19 principal treatments, anticoagulant raises a significant concern regarding the anticoagulant-related thrombocytopenia. However, up to date, there is lack of study examining anticoagulantinduced thrombocytopenia during COVID-19, hence this study was conducted to determine the factors inducing anticoagulant-induced thrombocytopenia in COVID-19 patients.METHODS: An observational cross-sectional study of 106 anticoagulant-treated COVID-19 subjects was conducted. Blood serum was drawn from subjects, then platelets, prothrombin time (PT), activated partial thromboplastin (aPPT), international ratio (INR), D-dimer, ferritin, fibrinogen, and high-sensitivity C-reactive protein (hs-CRP), were measured. For thrombocytopenia risk assessment, the 4T score was calculated. To assess the risk of thrombocytopenia. Statistical analysis using Chi-square and Mann-Whitney U test were performed and followed by multivariate analysis to examine the correlation among the thrombocytopenia risk factors.RESULTS: Significant differences were identified in the length of stay (LOS) (p=0.04), disease severity (p=0.021), sepsis (p=0.006), hs-CRP (p=0.003), and mortality rate (p=0.028) between thrombocytopenia and nonthrombocytopenia groups. A multivariate analysis through linear and logistic regression disclosed an increase in hs-CRP (OR=-0.29; p=0.045) and sepsis (OR=4.32; p=0.03)that precipitate the thrombocytopenia events.CONCLUSION: In severe and critically ill COVID-19 patients, the occurrence of thrombocytopenia was followed by an increase in inflammatory parameters such as D-dimer, fibrinogen, ferritin, hs-CRP and prolonged coagulation. The increase in hs-CRP and sepsis may raise the risk of thrombocytopenia, especially in severe and crtically ill cases of COVID-19.KEYWORDS: COVID-19, anticoagulant, thrombocytopenia, inflammation, infectious disease

Kata kunci

Jaringan kolaborasi para penulis

23 penulis · 101 tautan kepenulisan bersama · 8 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Ollscoil na Gaillimhe – University of Galway
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andi Yasmin WijayaUniversitas Airlangga5
Winona May HendrataUniversitas Airlangga5
Ugroseno Yudho BintoroAfiliasi tidak diketahui4
Made Putra SedanaAfiliasi tidak diketahui4
Muhammad Noor MuhammadAfiliasi tidak diketahui4
Ario DjatmikoAfiliasi tidak diketahui1
Wiwien RistantoAfiliasi tidak diketahui1
Lies MardiyanaAfiliasi tidak diketahui1
Sindrawati SindrawatiAfiliasi tidak diketahui1
Fedik Abdul RantamUniversitas Airlangga1
I Ketut SudianaUniversitas Airlangga1
Abdurachman AbdurachmanUniversitas Airlangga1
Lukman HakimUniversitas Airlangga1
Reny I’tishomUniversitas Airlangga1
Steven Sheng LooiOllscoil na Gaillimhe – University of Galway1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Increased hs-CRP and Sepsis Influence the Occurrence of Thrombocytopenia in Severe and Critically Ill COVID-19 Patients Receiving Anticoagulants</dc:title><dc:creator>Ami Ashariati</dc:creator><dc:creator>Siprianus Ugroseno Yudho Bintoro</dc:creator><dc:creator>Pradana Zaky Romadhon</dc:creator><dc:creator>Muhammad Noor Diansyah</dc:creator><dc:creator>Putu Niken Ayu Amrita</dc:creator><dc:creator>Merlyna Savitri</dc:creator><dc:creator>Choirina Windradi</dc:creator><dc:creator>Krisnina Nurul Widiyastuti</dc:creator><dc:subject>COVID-19 pandemic</dc:subject><dc:subject>high-sensitivity C-reactive protein</dc:subject><dc:subject>sepsis</dc:subject><dc:subject>critically ill patients</dc:subject><dc:subject>inflammation</dc:subject><dc:subject>D-dimer</dc:subject><dc:subject>fibrinogen</dc:subject><dc:subject>ferritin</dc:subject><dc:subject>coagulation</dc:subject><dc:subject>4Ts score</dc:subject><dc:subject>mortality</dc:subject><dc:subject>disease severity</dc:subject><dc:subject>length of hospital stay</dc:subject><dc:description xml:lang="en">BACKGROUND: Despites its benefits, as one of COVID-19 principal treatments, anticoagulant raises a significant concern regarding the anticoagulant-related thrombocytopenia. However, up to date, there is lack of study examining anticoagulantinduced thrombocytopenia during COVID-19, hence this study was conducted to determine the factors inducing anticoagulant-induced thrombocytopenia in COVID-19 patients.METHODS: An observational cross-sectional study of 106 anticoagulant-treated COVID-19 subjects was conducted. Blood serum was drawn from subjects, then platelets, prothrombin time (PT), activated partial thromboplastin (aPPT), international ratio (INR), D-dimer, ferritin, fibrinogen, and high-sensitivity C-reactive protein (hs-CRP), were measured. For thrombocytopenia risk assessment, the 4T score was calculated. To assess the risk of thrombocytopenia. Statistical analysis using Chi-square and Mann-Whitney U test were performed and followed by multivariate analysis to examine the correlation among the thrombocytopenia risk factors.RESULTS: Significant differences were identified in the length of stay (LOS) (p=0.04), disease severity (p=0.021), sepsis (p=0.006), hs-CRP (p=0.003), and mortality rate (p=0.028) between thrombocytopenia and nonthrombocytopenia groups. A multivariate analysis through linear and logistic regression disclosed an increase in hs-CRP (OR=-0.29; p=0.045) and sepsis (OR=4.32; p=0.03)that precipitate the thrombocytopenia events.CONCLUSION: In severe and critically ill COVID-19 patients, the occurrence of thrombocytopenia was followed by an increase in inflammatory parameters such as D-dimer, fibrinogen, ferritin, hs-CRP and prolonged coagulation. The increase in hs-CRP and sepsis may raise the risk of thrombocytopenia, especially in severe and crtically ill cases of COVID-19.KEYWORDS: COVID-19, anticoagulant, thrombocytopenia, inflammation, infectious disease</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2023-02-23</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>http://dx.doi.org/10.18585/inabj.v15i1.2045</dc:identifier><dc:identifier>10.18585/inabj.v15i1.2045</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 15 No 1 (2023); 77-84</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/2045/623</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>